5de Man-Van Ginkel JM,Hafsteinsdóttir TB,Lindeman E,et al.In-hospital risk prediction for post-stroke depression:development and validation of the Post-Stroke Depression Prediction Scale[J].Stroke,2013,44:2 441-2 445.
6Hollender KD.Screening,diagnosis,and treatment of post-stroke depression[J].J Neurosci Nurs,2014,46:135-141.
7Sibolt G,Curtze S,Melkas S,et al.Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke[J].Cerebrovasc Dis,2013,36:336-343.
8Zhang LS,Hu XY,Yao LY,et al.Prophylactic effects of duloxetine on post-stroke depression symptoms:an open single-blind trial[J].Eur Neurol,2013,69:336-343.
9Norio Watanabe, Ichiro M Omori, Atsuo Nakagawa, et al. Mirtazapine versus other antidepressive agents for depression. Coehrane Database Syst Rev,2011,11 (12) :6528.
10Colfax GN, Santos GM, Das M,et al. Mirtazapine to reduce metham- phetamine use: A randomized controlled trial. Arch Gen Psychiatry, 2011,68(11) :1168 -1175.
